PCRXPacira BioSciences, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 19970
Ticker: PCRX
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2011-02-03
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: PCRX

Detail

Enriched 2026-08-14 20:47

Market cap: $944,726,698.2
Shares outstanding (class): 39,861,886
Shares outstanding (weighted): 39,861,886
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 829
Location: BRISBANE, CA
Homepage: https://www.pacira.com
Description: Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Market cap and share counts drift.

Funds holding this security

142 funds · 143 positions · $263.12M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
iShares Core S&P Small-Cap ETF iShares Trust	IJR	$55.71M	0.06%	2,465,120 NS	FIGI
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$29.02M	0.00%	1,283,992 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$22.63M	0.03%	1,001,233 NS	FIGI
VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS	VB	$20.11M	0.01%	889,628 NS	FIGI
Impax Small Cap Fund IMPAX FUNDS SERIES TRUST I	—	$16.95M	2.29%	750,027 NS	FIGI
VANGUARD SMALL-CAP VALUE INDEX FUND VANGUARD INDEX FUNDS	VBR	$12.77M	0.02%	564,930 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$10.41M	0.01%	460,644 NS	FIGI
State Street(R) SPDR(R) Portfolio S&P 600(TM) S… SPDR SERIES TRUST	SPSM	$8.35M	0.06%	369,636 NS	FIGI
iShares S&P Small-Cap 600 Growth ETF iShares Trust	IJT	$8.00M	0.12%	354,122 NS	FIGI
DWS Small Cap Core Fund DEUTSCHE DWS INVESTMENT TRUST	—	$7.91M	0.75%	349,906 NS	FIGI
iShares Russell 2000 Value ETF iShares Trust	IWN	$7.24M	0.06%	320,442 NS	FIGI
State Street(R) SPDR(R) S&P(R) Pharmaceuticals … SPDR SERIES TRUST	XPH	$5.84M	1.90%	258,586 NS	FIGI
VANGUARD TAX-MANAGED SMALL-CAP FUND VANGUARD TAX-MANAGED FUNDS	—	$5.73M	0.06%	253,547 NS	FIGI
State Street(R) SPDR(R) S & P 600(TM) Small Cap… SPDR SERIES TRUST	SLYG	$4.90M	0.12%	216,832 NS	FIGI
VictoryShares Small Cap Free Cash Flow ETF Victory Portfolios II	SFLO	$3.03M	0.62%	134,240 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERPCRX
FIGI_COMPOSITEBBG0018FQNS6
FIGI_SHARE_CLASSBBG001S77N12
CIK0001396814
ISINUS6951271005
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Pacira BioSciences is a pharmaceutical company developing and commercializing non-opioid pain management products.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.